FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)

Lobbying for SKYHAWK THERAPEUTICS, INC. · Biotech company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $90,000.00 income · posted Jul 16, 2026

Lobbying activity 1

Health Issues

Lobbying related to rare disease innovation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem